After decades of consolidation by Big Pharma, demand for modern lab and diagnostic space in New Jersey is on the rise, fueling rent growth and pushing some developers to consider new laboratory projects.
The brokerage team that has sold many of New Jersey’s most high-profile pharmaceutical campuses has its latest assignment — the 1.14 million-square-foot Bristol-Myers Squibb research and development complex in Hopewell.
